Cancer Clinical Trial Using Trametinib and Dabrafenib

- The folks at GlaxoSmithKline are studying the effects of Dabrafenib; Trametinib on Cancer in individuals ages 18 years and older. This clinical trial is slated to start June 2011 and is expected to end circa September 2019.

877-379-3718
US GSK Clinical Call Center
Overall Study Contact Info
StatusName Contact Phone
RecruitingUS GSK Clinical Call CenterGSKClinicalSupportHD@gsk.com877-379-3718

This study is officially titled, "A Phase II Study of the BRAF Inhibitor Dabrafenib as a Single Agent and in Combination With the MEK Inhibitor Trametinib in Subjects With BRAF V600E Mutation Positive Metastatic (Stage IV) Non-small Cell Lung Cancer."

Locations

GSK Investigational Site

Oxford, United Kingdom - Recruiting

GSK Investigational Site

Manchester, United Kingdom - Not yet recruiting

GSK Investigational Site

London, United Kingdom - Not yet recruiting

GSK Investigational Site

Sutton, Surrey - Recruiting

GSK Investigational Site

London, United Kingdom - Not yet recruiting

GSK Investigational Site

Taipei, Taiwan - Recruiting

GSK Investigational Site

Taichung, Taiwan - Recruiting

GSK Investigational Site

Valencia, Spain - Not yet recruiting

GSK Investigational Site

Valencia, Spain - Not yet recruiting

GSK Investigational Site

Sevilla, Spain - Not yet recruiting

GSK Investigational Site

Pamplona, Spain - Recruiting

GSK Investigational Site

Oviedo, Spain - Not yet recruiting

GSK Investigational Site

Málaga, Spain - Recruiting

GSK Investigational Site

Palma de Mallorca, Spain - Not yet recruiting

GSK Investigational Site

Madrid, Spain - Not yet recruiting

GSK Investigational Site

Madrid, Spain - Not yet recruiting

GSK Investigational Site

Madrid, Spain - Recruiting

GSK Investigational Site

Madrid, Spain - Recruiting

GSK Investigational Site

Las Palmas De Gran Canaria, Spain - Not yet recruiting

GSK Investigational Site

Barcelona, Spain - Recruiting

GSK Investigational Site

Granada, Spain - Not yet recruiting

GSK Investigational Site

La Coru¤a, Spain - Not yet recruiting

GSK Investigational Site

Barcelona, Spain - Not yet recruiting

GSK Investigational Site

Badalona, Spain - Not yet recruiting

GSK Investigational Site

Alicante, Spain - Not yet recruiting

GSK Investigational Site

Seoul, Korea, Republic of - Recruiting

GSK Investigational Site

Oslo, Norway - Recruiting

GSK Investigational Site

Groningen, Netherlands - Recruiting

GSK Investigational Site

Amsterdam, Netherlands - Recruiting

GSK Investigational Site

Seoul, Korea, Republic of - Recruiting

GSK Investigational Site

Seoul, Korea, Republic of - Recruiting

GSK Investigational Site

Tokyo, Japan - Not yet recruiting

GSK Investigational Site

Milano, Lombardia - Recruiting

GSK Investigational Site

Osaka, Japan - Recruiting

GSK Investigational Site

Moers, Nordrhein-Westfalen - Not yet recruiting

GSK Investigational Site

Grosshansdorf, Schleswig-Holstein - Recruiting

GSK Investigational Site

Gauting, Bayern - Not yet recruiting

GSK Investigational Site

Heidelberg, Baden-Wuerttemberg - Recruiting

GSK Investigational Site

Frankfurt/Main, Hessen - Not yet recruiting

GSK Investigational Site

Villejuif Cedex, France - Recruiting

GSK Investigational Site

Toulouse cedex 9, France - Recruiting

GSK Investigational Site

Strasbourg cedex, France - Recruiting

GSK Investigational Site

Paris Cedex 12, France - Terminated

GSK Investigational Site

Pierre Benite, France - Recruiting

GSK Investigational Site

Saint-Herblain cedex, France - Recruiting

GSK Investigational Site

Marseille cedex 20, France - Recruiting

GSK Investigational Site

Lille cedex, France - Recruiting

GSK Investigational Site

Caen Cedex 9, France - Not yet recruiting

GSK Investigational Site

Seattle, Washington - Recruiting

GSK Investigational Site

Pittsburgh, Pennsylvania - Recruiting

GSK Investigational Site

Nashville, Tennessee - Not yet recruiting

GSK Investigational Site

Columbus, Ohio - Recruiting

GSK Investigational Site

New York, New York - Recruiting

GSK Investigational Site

Chapel Hill, North Carolina - Terminated

GSK Investigational Site

Rochester, Minnesota - Not yet recruiting

GSK Investigational Site

Boston, Massachusetts - Recruiting

GSK Investigational Site

Lebanon, New Hampshire - Recruiting

GSK Investigational Site

St Louis, Missouri - Not yet recruiting

GSK Investigational Site

Baltimore, Maryland - Recruiting

GSK Investigational Site

Tampa, Florida - Recruiting

GSK Investigational Site

Aurora, Colorado - Recruiting

GSK Investigational Site

Orange, California - Not yet recruiting

GSK Investigational Site

Los Angeles, California - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.